← All trials
NCT05516212
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 29, 2022
- Primary completion
- Dec 31, 2022
- Completion date
- Jun 30, 2023
- First posted
- Aug 25, 2022
- Last posted
- Aug 25, 2022
- Enrollment
- 25
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Poznan UniversityLead sponsor
- Poznan UniversityCollaborator
- Poznan UniversityOverall official - principal investigator
- Poznan UniversityReponsible party - principal investigator
- Poznan UniversityStudy chair
- National Science Centre, PolandCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.